Tilco-Alginure GmbH – Trademark Portfolio

Entity Type: 27

Tilco-Alginure GmbH holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include BONCROP, ALGISIUM, ASCOPHOS, and BONCROP ERFOLG ERNTEN.

Holländerkoppel 1A

23858 Reinfeld

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Tilco-Alginure GmbH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Tilco-Alginure GmbH have?

Tilco-Alginure GmbH has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 cancelled.

What trademark classes does Tilco-Alginure GmbH file in?

Tilco-Alginure GmbH files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Tilco-Alginure GmbH's most well-known trademarks?

Tilco-Alginure GmbH's registered trademark portfolio includes well-known marks such as BONCROP, ALGISIUM, ASCOPHOS, and BONCROP ERFOLG ERNTEN. These are among 4 currently registered trademarks in the portfolio.

What is Tilco-Alginure GmbH's trademark registration success rate?

Tilco-Alginure GmbH has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.